Zimmer Biomet Holdings, Inc. (ZBH) Free Cash Flow (FCF): $1.84B
The free cash flow (FCF) for Zimmer Biomet Holdings, Inc. (ZBH) is $1.84B. It is above its 12-month average by 40.38% ($1.31B).
ZBH Free Cash Flow (FCF) Chart
ZBH Average Free Cash Flow (FCF) Chart
ZBH Current vs Average Free Cash Flow (FCF) Chart
ZBH Free Cash Flow (FCF) Metrics
FREE CASH FLOW (FCF)
$1.84B
FREE CASH FLOW (FCF) AVG TTM
$1.31B
FREE CASH FLOW (FCF) AVG 3Y
$1.22B
FREE CASH FLOW (FCF) AVG 5Y
$1.22B
FREE CASH FLOW (FCF) AVG 10Y
$1.24B
FREE CASH FLOW (FCF) AVG 15Y
$1.16B
FREE CASH FLOW (FCF) AVG 20Y
$1.06B
CURRENT VS TTM AVG
+40.38%
CURRENT VS 3Y AVG
+50.78%
CURRENT VS 5Y AVG
+50.68%
CURRENT VS 10Y AVG
+48.12%
CURRENT VS 15Y AVG
+57.76%
CURRENT VS 20Y AVG
+73.57%
FCF Analysis
Free Cash Flow (TTM)
$1.84B
FCF Yield
10.66%
Price/FCF
9.4
Formula: FCF = Operating Cash Flow - Capital Expenditures
Why FCF matters:
- Shows actual cash available (not accounting earnings)
- Funds dividends, buybacks, and debt reduction
- Less susceptible to accounting manipulation than net income
- Key metric for DCF valuation models
Zimmer Biomet Holdings, Inc. Free Cash Flow (FCF) Formula & Definition
Free Cash Flow represents the cash a company generates after accounting for capital expenditures. It's the cash available for dividends, buybacks, debt reduction, or reinvestment.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Zimmer Biomet Holdings, Inc. Free Cash Flow (FCF) FAQ
- What is the free cash flow (FCF) for Zimmer Biomet Holdings, Inc. (ZBH)?
- The free cash flow (FCF) for ZBH stock is $1.84B.
- What is the TTM average free cash flow (FCF) for Zimmer Biomet Holdings, Inc. (ZBH)?
- The TTM average free cash flow (FCF) for ZBH stock is $1.31B.
- What is the 3Y average free cash flow (FCF) for Zimmer Biomet Holdings, Inc. (ZBH)?
- The 3Y average free cash flow (FCF) for ZBH stock is $1.22B.
- What is the 5Y average free cash flow (FCF) for Zimmer Biomet Holdings, Inc. (ZBH)?
- The 5Y average free cash flow (FCF) for ZBH stock is $1.22B.
- What is the 10Y average free cash flow (FCF) for Zimmer Biomet Holdings, Inc. (ZBH)?
- The 10Y average free cash flow (FCF) for ZBH stock is $1.24B.
- What is the 15Y average free cash flow (FCF) for Zimmer Biomet Holdings, Inc. (ZBH)?
- The 15Y average free cash flow (FCF) for ZBH stock is $1.16B.
- What is the 20Y average free cash flow (FCF) for Zimmer Biomet Holdings, Inc. (ZBH)?
- The 20Y average free cash flow (FCF) for ZBH stock is $1.06B.
Zimmer Biomet Holdings, Inc. Free Cash Flow (FCF) History
| DATE | FREE CASH FLOW (FCF) |
|---|---|
| 2025-12-31 | $1.47B |
| 2024-12-31 | $1.14B |
| 2023-12-31 | $1.19B |
| 2022-12-31 | $1.07B |
| 2021-12-31 | $1.35B |
| 2020-12-31 | $1.09B |
| 2019-12-31 | $1.18B |
| 2018-12-31 | $1.58B |
| 2017-12-31 | $1.43B |
| 2016-12-31 | $1.45B |
| 2015-12-31 | $682.10M |
| 2014-12-31 | $915.60M |
| 2013-12-31 | $863.10M |
| 2012-12-31 | $1.04B |
| 2011-12-31 | $1.06B |
| 2010-12-31 | $1.11B |
| 2009-12-31 | $852.90M |
| 2008-12-31 | $440.80M |
| 2007-12-31 | $753.20M |
| 2006-12-31 | $772.40M |
| 2005-12-31 | $772.90M |
| 2004-12-31 | $761.40M |
| 2003-12-31 | $336.30M |
| 2002-12-31 | $186.50M |
| 2001-12-31 | $117.10M |
| 2000-12-31 | $203.40M |
| 1999-12-31 | $147.00M |
| 1998-12-31 | $179.00M |
Related Metrics
About Zimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings, Inc. (ZBH), along with its global subsidiaries, operates as a leading player in the musculoskeletal healthcare sector. The company extends its reach across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. ZBH is responsible for the design, manufacturing, and marketing of a wide array of orthopedic reconstructive solutions, including prominent knee and hip replacement systems. Their offerings also encompass Specialized Enabling Technologies (S.E.T.) products, which cover areas such as sports medicine, biologics, foot and ankle care, extremity treatments, and trauma management. Furthermore, the company provides medical devices and surgical instruments specifically for spinal conditions, alongside products for facial and cranial reconstruction. A unique part of their portfolio includes systems designed to stabilize and fixate chest bones, facilitating recovery or reconstruction following open-heart surgery, traumatic injuries, or congenital chest deformities. The company's product lines also feature a comprehensive range of dental solutions, such as reconstructive implants, prosthetics, and regenerative materials. Additionally, they are involved in robotic surgical systems, general surgical instruments, and bone cements. These advanced products and solutions are primarily utilized to address conditions in patients suffering from disorders or injuries affecting bones, joints, and their associated soft tissues. Zimmer Biomet caters to a broad clientele, including orthopedic, neuro-, and oral surgeons, dentists, hospitals, independent distributors, healthcare suppliers, and various other medical specialists. Their network further encompasses agents, healthcare purchasing organizations, and group buying alliances. Originally established in 1927, the enterprise was initially known as Zimmer Holdings, Inc., before rebranding as Zimmer Biomet Holdings, Inc. in June 2015. Its corporate headquarters are situated in Warsaw, Indiana.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Ivan Tornos